Navigation Links
Engineered E. coli produces high levels of D-ribose as described in Industrial Biotechnology journal
Date:4/24/2014

New Rochelle, NY, April 24, 2014D-ribose is a commercially important sugar used as a sweetener, a nutritional supplement, and as a starting compound for synthesizing riboflavin and several antiviral drugs. Genetic engineering of Escherichia coli to increase the bacteria's ability to produce D-ribose is a critical step toward achieving more efficient industrial-scale production of this valuable chemical, as described in an article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Industrial Biotechnology website.

In "Engineering Escherichia coli for D-Ribose Production from Glucose-Xylose Mixtures." Pratish Gawand and Radhakrishnan Mahadevan, University of Toronto, Canada, describe the metabolic engineering strategy they used to increase the yield of D-ribose from the genetically modified E. coli, which were able to produce D-ribose from mixtures of glucose and xylose. The authors propose future research directions for additional metabolic engineering and bioprocess optimization.

"The research article by Gawand and Mahadevan represents one of many ways that molecular biology is being deployed to expand Industrial Biotechnology development," says Co-Editor-in-Chief Larry Walker, PhD, Professor, Biological & Environmental Engineering, Cornell University, Ithaca, NY.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. Engineered bacteria produce biofuel alternative for high-energy rocket fuel
2. New biological scaffold offers promising foundation for engineered tissues
3. Scientists develop an engineered cardiac tissue model to study the human heart
4. Engineered virus is effective against triple negative breast cancer cells
5. High-tech X-ray imaging technique to offer detailed look at engineered tissue
6. Researchers develop new approach to identify possible ecological effects of releasing genetically engineered insects
7. Novel technique for suturing tissue-engineered collagen graft improves tendon repair
8. Bioinspired and Nanoengineered Surfaces: Technologies, Applications and Global Markets
9. Engineered stem cell advance points toward treatment for ALS
10. Engineered microbes grow in the dark
11. Europe needs genetically engineered crops, scientists say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Engineered E. coli produces high levels of D-ribose as described in Industrial Biotechnology journal
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):
(Date:8/10/2017)... (PRWEB) , ... August 09, 2017 , ... ... to help the agriculture industry reach its ideal customers with the right message. ... nation. , “As a Midwest company, we realize how crucial the agriculture industry ...
(Date:8/10/2017)... ... August 09, 2017 , ... ... applications in the clinic is here. The team at Capricor Therapeutics, Inc. utilized ... medium for clinical studies. , Dr. Travis Antes, head of analytical development ...
(Date:8/10/2017)... ... August 09, 2017 , ... Okyanos Center for Regenerative Medicine has announced ... Bay Hotel in Freeport, Grand Bahama on September 27, 2017. This daytime event is ... oversight from the Ministry of Health’s National Stem Cell Ethics Committee (NSCEC) and regulations ...
(Date:8/10/2017)... ... August 10, 2017 , ... DrugDev and the Society for ... demonstrate how Good Clinical Practice (GCP) can be used throughout the site activation process ... discuss the importance of GCP compliance, how sites are affected by GCP during selection ...
Breaking Biology Technology: